3D Global Biotech Statistics

Total Valuation

TPEX:6808 has a market cap or net worth of TWD 4.77 billion. The enterprise value is 4.44 billion.

Market Cap	4.77B
Enterprise Value	4.44B

Important Dates

The last earnings date was Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6808 has 77.84 million shares outstanding. The number of shares has increased by 7.54% in one year.

Current Share Class	n/a
Shares Outstanding	77.84M
Shares Change (YoY)	+7.54%
Shares Change (QoQ)	+12.70%
Owned by Insiders (%)	29.67%
Owned by Institutions (%)	3.21%
Float	45.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	66.67
PB Ratio	8.96
P/TBV Ratio	13.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-150.89
EV / Sales	80.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-324.91

Financial Position

The company has a current ratio of 6.79, with a Debt / Equity ratio of 0.02.

Current Ratio	6.79
Quick Ratio	5.98
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.52
Interest Coverage	-267.38

Financial Efficiency

Return on equity (ROE) is -7.64% and return on invested capital (ROIC) is -5.54%.

Return on Equity (ROE)	-7.64%
Return on Assets (ROA)	-5.11%
Return on Invested Capital (ROIC)	-5.54%
Return on Capital Employed (ROCE)	-7.65%
Revenue Per Employee	1.67M
Profits Per Employee	-891,152
Employee Count	33
Asset Turnover	0.13
Inventory Turnover	0.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +109.97% in the last 52 weeks. The beta is 0.38, so TPEX:6808's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	+109.97%
50-Day Moving Average	60.47
200-Day Moving Average	46.07
Relative Strength Index (RSI)	50.31
Average Volume (20 Days)	665,938

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6808 had revenue of TWD 55.15 million and -29.41 million in losses. Loss per share was -0.49.

Revenue	55.15M
Gross Profit	35.36M
Operating Income	-35.03M
Pretax Income	-30.38M
Net Income	-29.41M
EBITDA	-18.79M
EBIT	-35.03M
Loss Per Share	-0.49

Full Income Statement

Balance Sheet

The company has 341.43 million in cash and 7.12 million in debt, giving a net cash position of 334.31 million or 4.29 per share.

Cash & Cash Equivalents	341.43M
Total Debt	7.12M
Net Cash	334.31M
Net Cash Per Share	4.29
Equity (Book Value)	457.04M
Book Value Per Share	6.84
Working Capital	333.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.05 million and capital expenditures -2.61 million, giving a free cash flow of -13.66 million.

Operating Cash Flow	-11.05M
Capital Expenditures	-2.61M
Free Cash Flow	-13.66M
FCF Per Share	-0.18

Full Cash Flow Statement

Margins

Gross margin is 64.12%, with operating and profit margins of -63.51% and -53.32%.

Gross Margin	64.12%
Operating Margin	-63.51%
Pretax Margin	-55.09%
Profit Margin	-53.32%
EBITDA Margin	-34.07%
EBIT Margin	-63.51%
FCF Margin	n/a

Dividends & Yields

TPEX:6808 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.54%
Shareholder Yield	-7.54%
Earnings Yield	-0.62%
FCF Yield	-0.29%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6808 has an Altman Z-Score of 15.73.

Altman Z-Score	15.73
Piotroski F-Score	n/a